Home /
Case study

Ensuring study integrity and reliability during a drug recall

Technology and services delivered on schedule

A safety recall, by definition, is fraught with tension given the ultimate risks and the need to act swiftly with no margin for error. During a clinical trial in which only a portion of the product or a specific kit type is being recalled, the study need not be jeopardised. But it must be meticulously managed.

When a Sponsor was faced with such a situation, the company’s CRO suggested that Almac’s trusted professionals be called. Working in
concert, Almac Clinical Technologies (ACT) and Almac Clinical Services (ACS) kept the study going without unblinding, losing patients, or delaying the trial.

View Resource
Almac Logo

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies